DUBLIN–(BUSINESS WIRE)–The “Pharmaceutical Drug Development Annual Review – 2024” report has been added to ResearchAndMarkets.com’s offering.
This report investigates the year 2024 in the pharmaceutical industry from the standpoint of drug development. It provides a high-level analysis of key trends and movements within the industry via regulatory, clinical, and market-based analysis, allowing you to discern the large-scale changes and how best to pivot to prioritize them within your sector.
This report gives important, expert insight you won’t find in any other source. 21 figures throughout the report illustrate major points and trends in future pharmaceutical sales forecasts and company pipelines.
This report is required reading for:
- Investors that want to understand past trends impacting the biopharmaceutical industry as well as identifying companies to invest in
- Companies that are interested in entering the biopharmaceutical space and where best to focus on
- Large pharma companies with investment groups or BD teams looking to see which companies lead the industry in the past and how they led
- Small and medium pharma who want to focus their drug portfolio on future trends and are looking for partnership opportunities
Reasons to Buy
- Insights on how drug development in 2024 may impact future approvals
- Insights on how drug approvals in 2024 may impact future drug development and approval trends
- Sales and regulatory-based insights into 2024 covering various drugs and companies
Key Topics Covered:
1 Executive Summary
2 2024 Pipeline Development
2.1 Top pipeline therapy areas
2. 2 Pipeline drugs by highest development stage
2.3 Top drugs by molecule type
2.4 Top drugs by target
3 2024 Approvals
3.1 FDA, EMA, Japan regulatory approvals, 2022-2024
3.2 US Fast Track Designation approvals, 2022-2024
3.3 Rare Pediatric disease designation approvals, 2022-2024
4 2024 Sales
4.1 2023 vs 2024 sales
4.2 2023 vs 2024 company market capitalization
5 Key Findings
6 Appendix
Companies Featured
- Pfizer
- Merck & Co
- Novartis AG
- Johnson & Johnson
- Abbvie
- F.Hoffman-La Roche Ltd
- Bristol-Myers Squibb Co
- Astrazeneca Plc
- GSK plc
- Bristol Myers-Squibb Co
- Sanofi
For more information about this report visit https://www.researchandmarkets.com/r/hctc4z
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
